Dimensional Fund Advisors’s Arcadia Biosciences RKDA Stock Holding History

Dimensional Fund Advisors’s Portfolio RKDA Stock Details RKDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,019	Closed	-$42K	–	3549
2021 Q4	$42K	Sell	1,019 -284	-22%	-$18.5K	﹤0.01%	3503
2021 Q3	$108K	Buy	1,303 +39	+3%	+$3.66K	﹤0.01%	3418
2021 Q2	$150K	Buy	1,264 +956	+310%	+$104K	﹤0.01%	3375
2021 Q1	$34K	Sell	308 -65	-17%	-$7.97K	﹤0.01%	3400
2020 Q4	$38K	Hold	373	–	–	﹤0.01%	3326
2020 Q3	$42K	Hold	373	–	–	﹤0.01%	3309
2020 Q2	$56K	Hold	373	–	–	﹤0.01%	3306
2020 Q1	$42K	Buy	+373	New	+$64.9K	﹤0.01%	3330
2019 Q2	–	Sell	-574	Closed	-$161K	–	3471
2019 Q1	$161K	Hold	574	–	–	﹤0.01%	3335
2018 Q4	$73K	Hold	574	–	–	﹤0.01%	3377
2018 Q3	$112K	Buy	+574	New	+$144K	﹤0.01%	3348

Other funds holding RKDA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Dimensional Fund Advisors's RKDA Position: Q1 2022 in Review

Dimensional Fund Advisors sold out of Arcadia Biosciences (RKDA) in Q1 2022, closing a stake of 1,019 shares — an estimated $42K sold.

Dimensional Fund Advisors first reported a position in RKDA in Q3 2018 and held it in 11 quarters. The position peaked at $161K in Q1 2019. 25 funds tracked by Wall St. Rank hold RKDA as of Q1 2022.

Dimensional Fund Advisors reported no remaining Arcadia Biosciences position as of Q1 2022 after selling out during the quarter.
Dimensional Fund Advisors sold 1,019 Arcadia Biosciences shares in Q1 2022, an estimated $42K.
Dimensional Fund Advisors first reported a position in Arcadia Biosciences in Q3 2018 and held it in 11 quarters.
Dimensional Fund Advisors's Arcadia Biosciences position peaked at $161K in Q1 2019.
25 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q1 2022.

Based on Dimensional Fund Advisors's 13F filing for Q1 2022, filed 13 May 2022.